#POLB Poolbeg Pharma PLC – Letter to Shareholders – 2025 a year of progress December 18, 2025 – Posted in: Poolbeg Pharma (POLB)

18 December 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, publishes an end of year letter from the Company’s Executive Chair, Cathal Friel, providing an overview of the significant progress made by the Company in 2025 and outlook for 2026.   Dear Shareholders,   As 2025 draws to a close, we wanted to reflect on the substantial progress made by Poolbeg this…

Continue reading

#VELA investee co. #ENSI EnSilica PLC – Proposed equity fundraising via ABB May 24, 2024 – Posted in: Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), today announces its intention to conduct a fundraising to raise gross proceeds of at least £4.3 million through (i) a placing (the “Placing”) of a minimum of 8,644,642 new ordinary shares (“Placing Shares”) of 0.1p each in the capital of the Company (“Ordinary Shares”) to new and existing institutional investors (“Placees”) at an issue price of 45 pence per new Ordinary Share (the “Issue Price”) and…

Continue reading

#VELA Vela Technologies Investee Co. – #TRYB Tribe Technology – Trading update December 29, 2023 – Posted in: Vela Technologies Plc (VELA)

Tribe Technology PLC (AIM: TRYB), a disruptive developer and manufacturer of autonomous mining equipment, provides the following trading update. Factory completion of the first generation autonomous TTDS 700 GC drill rig, originally anticipated to occur in late Q4 2023, is now expected to occur in Q1 2024. Significant progress has been made on the build of this pioneering system. However, completion of the rig delivery to the customer has been delayed primarily due to unanticipated…

Continue reading